Logo image of ZEO

ZEO ENERGY CORP (ZEO) Stock Fundamental Analysis

NASDAQ:ZEO - US98944F1093 - Common Stock

1.65 USD
+0.04 (+2.48%)
Last: 8/29/2025, 8:00:46 PM
1.65 USD
0 (0%)
After Hours: 8/29/2025, 8:00:46 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZEO. ZEO was compared to 92 industry peers in the Electrical Equipment industry. The financial health of ZEO is average, but there are quite some concerns on its profitability. ZEO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ZEO had negative earnings in the past year.
ZEO had a positive operating cash flow in the past year.
ZEO Yearly Net Income VS EBIT VS OCF VS FCFZEO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

The Return On Assets of ZEO (-18.66%) is comparable to the rest of the industry.
ZEO has a Return On Equity (-41.77%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -18.66%
ROE -41.77%
ROIC N/A
ROA(3y)-3.43%
ROA(5y)N/A
ROE(3y)-10.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZEO Yearly ROA, ROE, ROICZEO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

ZEO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEO Yearly Profit, Operating, Gross MarginsZEO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, ZEO has less shares outstanding
Compared to 1 year ago, ZEO has a worse debt to assets ratio.
ZEO Yearly Shares OutstandingZEO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M
ZEO Yearly Total Debt VS Total AssetsZEO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

ZEO has an Altman-Z score of 3.73. This indicates that ZEO is financially healthy and has little risk of bankruptcy at the moment.
ZEO has a better Altman-Z score (3.73) than 70.65% of its industry peers.
ZEO has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.98, ZEO belongs to the best of the industry, outperforming 88.04% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that ZEO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, ZEO is in line with its industry, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.98
Altman-Z 3.73
ROIC/WACCN/A
WACCN/A
ZEO Yearly LT Debt VS Equity VS FCFZEO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

ZEO has a Current Ratio of 0.01. This is a bad value and indicates that ZEO is not financially healthy enough and could expect problems in meeting its short term obligations.
ZEO has a Current ratio of 0.01. This is amonst the worse of the industry: ZEO underperforms 96.74% of its industry peers.
ZEO has a Quick Ratio of 0.01. This is a bad value and indicates that ZEO is not financially healthy enough and could expect problems in meeting its short term obligations.
ZEO has a Quick ratio of 0.01. This is amonst the worse of the industry: ZEO underperforms 96.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ZEO Yearly Current Assets VS Current LiabilitesZEO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

0

3. Growth

3.1 Past

The earnings per share for ZEO have decreased strongly by -165.49% in the last year.
EPS 1Y (TTM)-165.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZEO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEO Price Earnings VS Forward Price EarningsZEO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

66.30% of the companies in the same industry are more expensive than ZEO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 100.78
EV/EBITDA N/A
ZEO Per share dataZEO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZEO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZEO ENERGY CORP

NASDAQ:ZEO (8/29/2025, 8:00:46 PM)

After market: 1.65 0 (0%)

1.65

+0.04 (+2.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-13 2025-08-13
Earnings (Next)01-17 2026-01-17
Inst Owners38.5%
Inst Owner Change121.54%
Ins Owners33.1%
Ins Owner Change0%
Market Cap90.73M
AnalystsN/A
Price TargetN/A
Short Float %0.51%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 100.78
P/OCF 100.78
P/B 12.61
P/tB 12.61
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.99%
OCF(TTM)0.02
OCFY0.99%
SpS0
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.66%
ROE -41.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.43%
ROA(5y)N/A
ROE(3y)-10.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 1.98
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 3.73
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-165.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.55%
OCF growth 3YN/A
OCF growth 5YN/A